-
1
المؤلفون: Joseph Kattan, Elie El Rassy, Pamela Abdayem
المصدر: Future Oncology. 13:1451-1453
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Receptor, ErbB-2, Breast Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Second line, Internal medicine, Humans, Medicine, Molecular Targeted Therapy, 030212 general & internal medicine, Neoplasm Metastasis, Clinical Trials as Topic, Second line treatment, biology, business.industry, Cyclin-dependent kinase 4, TOR Serine-Threonine Kinases, Estrogen Receptor alpha, Cyclin-Dependent Kinase 4, General Medicine, Discovery and development of mTOR inhibitors, medicine.disease, Metastatic breast cancer, 030220 oncology & carcinogenesis, biology.protein, Female, Signal transduction, business, Estrogen receptor alpha, Signal Transduction
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83ed8541e954e069bf70d449deef3592Test
https://doi.org/10.2217/fon-2017-0190Test -
2
المصدر: Future Oncology. 11:1809-1828
مصطلحات موضوعية: Oncology, mTOR inhibitors, renal cell carcinoma, Cancer Research, medicine.medical_specialty, Antineoplastic Agents, mTORC1, Mechanistic Target of Rapamycin Complex 1, Neuroendocrine tumors, urologic and male genital diseases, medicine.disease_cause, everolimus, mTOR pathway, neuroendocrine neoplasm, temsirolimus, Animals, Carcinoma, Renal Cell, Clinical Trials as Topic, Humans, Kidney Neoplasms, Molecular Targeted Therapy, Multiprotein Complexes, Neuroendocrine Tumors, Signal Transduction, TOR Serine-Threonine Kinases, Renal cell carcinoma, Internal medicine, medicine, PI3K/AKT/mTOR pathway, Everolimus, business.industry, Carcinoma, Renal Cell, Cancer, General Medicine, medicine.disease, Temsirolimus, Carcinogenesis, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b67969dd2b52aa6ee442bc32e5d75ec5Test
https://doi.org/10.2217/fon.15.81Test